S-Adenosylmethionine and Nicotinamide Riboside Supplementation Improves Fatigue and Stabilizes Vision in PRPS1 Deficiency: Case Report
Objectives
To evaluate the impact of S-Adenosylmethionine (SAMe) and NR supplementation on the clinical symptoms of PRPS1 deficiency, specifically focusing on fatigue, cognitive decline, and vision impairment.
Journal
Ophthalmic Genetics
Key Outcomes
- Following the initiation of supplementation with SAMe and NR, the patient reported a marked improvement in fatigue, with no further deterioration in vision.
Duration
Approximately one year
Dose
SAMe: 1600 mg
NR: 800 mg
Study Design
Retrospective, observational, single-patient, clinical case study of a 26-year-old adult patient with a somatic mosaic pathogenic varient in the PRPS1 gene, diagnosed with PRPS1 deficiency